Skip to main content
Category

Stocks

InvestingStocks

Onward on the Verge of a Growth Spurt

The medtech company Onward, listed on Euronext Brussels, has launched its commercial rollout in the U.S. and is now attracting significant interest. Sales of its ARC-EX system are expected to accelerate, following the sale of 10 systems in the first quarter. Meanwhile, the company continues…
Francis Muyshondt
18 June 2025
Stocks

Nyxoah faces a moment of truth

The company now has enough money for commercialization in the US Nyxoah, a medtech company that combats sleep apnea with an implantable neurostimulator, signed an agreement with the European Investment Bank (EIB) for a credit facility of 37.5 million EUR at the beginning of July.…
EFI
11 July 2024